Navigation Links
Lilly Caps Successful Year with Strong Fourth-Quarter Results
Date:1/29/2008

2007, worldwide Byetta sales increased 51 percent, to $650.2 million. U.S. Byetta sales for 2007 were $636.0 million, a 48 percent increase driven by higher demand. Byetta sales outside the U.S. were $14.2 million. For 2007, Lilly recognized revenue totaling $330.7 million, representing a 51 percent increase compared with 2006.

Animal Health

Worldwide sales of animal health products in the fourth quarter were $329.4 million, an increase of 27 percent compared with the fourth quarter of 2006. U.S. sales grew 37 percent to $179.7 million driven by increased demand, the acquisition of Ivy Animal Health, Inc. and new companion animal product launches. Sales outside the U.S. grew 16 percent to $149.7 million driven by increased demand, the favorable impact of exchange rates and higher prices.

For the full year of 2007, worldwide sales of animal health products increased 14 percent, to $995.8 million. U.S. animal health sales for 2007 were $480.9 million, an 18 percent increase driven by increased demand, the acquisition of Ivy Animal Health, and new companion animal product launches. Animal health sales outside the U.S. were $514.9 million, a 10 percent increase, driven by favorable exchange rates and increased demand.

2008 Financial Guidance

The company confirmed its full-year 2008 financial guidance. For 2008, the company expects pro forma sales to grow in the mid- to high-single digits, driven primarily by increased volume and strong sales growth for Cymbalta, Cialis, Byetta, Alimta and Humalog. The company expects modest improvement in gross margin as a percent of sales, driven primarily by manufacturing expenses growing more slowly than sales. Total operating expenses are also expected to grow more slowly than sales, with growth in the mid-single digits. Marketing, selling and administrative expenses are expected to grow in the low-single digits, driven by investments in prasugrel, Cymbalta, Evista for invasive breast cancer risk r
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
2. Lilly Announces Dividend Increase
3. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
4. International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
5. JDRF and Lilly partner to fund research to identify beta cell biomarkers
6. The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
7. Lilly Contributes $10.8 Million to United Way Annual Campaign
8. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
9. Lilly Sets Date and Time for American Heart Association Conference Call
10. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
11. Eli Lilly and Company Aids California Recovery Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Traveling to ... a wide array of magnificent flora and fauna. , Lifestyle Holidays Vacation ... well-preserved history. To help make travelers experience that much better, Lifestyle Holidays Vacation Club ...
(Date:9/1/2015)... Hills, CA (PRWEB) , ... September 01, 2015 ... ... International Business Times discusses the hundreds of thousands of plastic surgeries conducted each ... media and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam ...
(Date:9/1/2015)... ... , ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills ... year in the United States. , Prostate cancer is to men what breast cancer ... in 7 men. One new case occurs every 2.3 minutes and a man dies ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ has ... of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA ... demonstrating its safety when used at home to combat hair loss. , ...
Breaking Medicine News(10 mins):Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
(Date:9/1/2015)... BEDFORD, Mass. , Sept. 1, 2015 ... investigating whether certain officers and directors of ... Act of 1934.  ConforMIS is a medical technology company ... manufacture, and sell joint replacement implants that are individually ... View this press release on the law ...
(Date:9/1/2015)... Va. , Sept. 1, 2015  AccuTec Blades, ... Company,s (EPC) Industrial Blades division.  EPC announced in May ... in Verona, Virginia and ... completion of the sale process. ... Officer of AccuTec Blades said, "Our new name, AccuTec ...
(Date:9/1/2015)... BRUSSELS , Sept. 1, 2015 /PRNewswire/ ... Brussels: UCB) today announced top-line results from the ... with Teriparatide in postmenopaUsal women with osteoporosis at ... therapy). The study (NCT01796301) met the primary endpoint, ... romosozumab in the percent change of total hip ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9
... Adding MabThera to first line chemotherapy significantly,increases ... May, 2007) _ In a study published,yesterday ... (rituximab),plus chemotherapy (MCP*) was shown to significantly ... compared to,chemotherapy alone.1 Follicular lymphoma is the ...
... of 10 non-diabetic patients treated with,Exforge achieved recommended blood ... mmHg in,systolic blood pressure observed in patients taking Exforge ... of those with high blood pressure not,at treatment target ... goal[2] , , , BASEL, ...
Cached Medicine Technology:Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 2Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 3Innovative Cancer Drug MabThera Again Shown To Improve Survival,Rates In Patients With Lymphoma 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 2Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 3Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 4Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 5Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 6Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 7Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data 8
... VerdaSee Mobile Location-ID™ offers a for asset ... are attached to all the assets that will ... device, is equipped with a reader, antenna, and ... be as small as 10 inches x 6 ...
... provides hospitals with a suite ... all their supplies, drugs, assets, ... remove all manual compliance from ... accurately. iRIS, or Intelligent Radio-Frequency ...
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
Medicine Products: